Alibaba Health Information Technology Limited

ALBBYOTCHealthcare● Active

$9.01

$-0.05(-0.50%)

Market Cap$7.3B

P/E Ratio—

52W High$19.45

52W Low$8.95

Avg Volume109

Open$9.01

Beta1.60

Earnings Financials Revenue

Alibaba Health Information Technology Limited (ALBBY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ALBBY · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: May 18, 2026

EPS Actual

$0.12

Revenue

$2.51B

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 18, 2026

After Market Close

ALBBY reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.09

Rev. $41.31B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.09

Rev. Est.$41.31B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 18, 2026	—	$0.12	—	$2.51B	—	—
— Q4 FY2025	Nov 13, 2025	—	$0.22	—	$2.32B	—	—
— Q2 FY2025	May 19, 2025	—	$0.11	—	$2.24B	—	—
— Q4 FY2024	Dec 31, 2024	—	$0.06	—	$1.12B	—	—
— Q4 FY2024	Nov 13, 2024	—	$0.14	—	$2.03B	—	—
— Q2 FY2024	May 27, 2024	—	$0.08	—	$1.95B	—	—
— Q1 FY2024	Mar 26, 2024	—	$0.09	—	$1.77B	—	—
— Q1 FY2023	Mar 31, 2023	—	$0.08	—	$2.22B	—	—

Q2 FY2026

May 18, 2026

EPS Actual

$0.12

EPS Est.

—

EPS Surpr.

—

Revenue

$2.51B

Q4 FY2025

Nov 13, 2025

EPS Actual

$0.22

EPS Est.

—

EPS Surpr.

—

Revenue

$2.32B

Q2 FY2025

May 19, 2025

EPS Actual

$0.11

EPS Est.

—

EPS Surpr.

—

Revenue

$2.24B

Q4 FY2024

Dec 31, 2024

EPS Actual

$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

$1.12B

Q4 FY2024

Nov 13, 2024

EPS Actual

$0.14

EPS Est.

—

EPS Surpr.

—

Revenue

$2.03B

Q2 FY2024

May 27, 2024

EPS Actual

$0.08

EPS Est.

—

EPS Surpr.

—

Revenue

$1.95B

Q1 FY2024

Mar 26, 2024

EPS Actual

$0.09

EPS Est.

—

EPS Surpr.

—

Revenue

$1.77B

Q1 FY2023

Mar 31, 2023

EPS Actual

$0.08

EPS Est.

—

EPS Surpr.

—

Revenue

$2.22B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 18, 2026	—	$11.16	$11.16	+0.00%
— Q4 FY2025	Nov 13, 2025	—	$14.72	$14.72	+0.00%
— Q2 FY2025	May 19, 2025	—	$14.00	$14.00	+0.00%
— Q4 FY2024	Dec 31, 2024	—	$8.72	$8.72	+0.00%
— Q4 FY2024	Nov 13, 2024	—	$10.52	$10.43	-0.86%
— Q2 FY2024	May 27, 2024	—	$7.65	$8.74	+14.25%
— Q1 FY2024	Mar 26, 2024	—	$9.00	$7.87	-12.56%
— Q1 FY2023	Mar 31, 2023	—	$14.60	$14.51	-0.62%

Q2 FY2026+0.00%

Report Date

May 18, 2026

EPS Beat/Miss

—

Price Before

$11.16

Price After

$11.16

Q4 FY2025+0.00%

Report Date

Nov 13, 2025

EPS Beat/Miss

—

Price Before

$14.72

Price After

$14.72

Q2 FY2025+0.00%

Report Date

May 19, 2025

EPS Beat/Miss

—

Price Before

$14.00

Price After

$14.00

Q4 FY2024+0.00%

Report Date

Dec 31, 2024

EPS Beat/Miss

—

Price Before

$8.72

Price After

$8.72

Q4 FY2024-0.86%

Report Date

Nov 13, 2024

EPS Beat/Miss

—

Price Before

$10.52

Price After

$10.43

Q2 FY2024+14.25%

Report Date

May 27, 2024

EPS Beat/Miss

—

Price Before

$7.65

Price After

$8.74

Q1 FY2024-12.56%

Report Date

Mar 26, 2024

EPS Beat/Miss

—

Price Before

$9.00

Price After

$7.87

Q1 FY2023-0.62%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$14.60

Price After

$14.51

Beat Rate0 / 8 quarters

Largest Move+14.25% (Q2 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Alibaba Health Information Technology Limited (ALBBY) most recently reported earnings on May 18, 2026 for Q2 FY2026, posting EPS of $0.12 (in line with the analyst consensus of —). The next ALBBY earnings date is expected around September 1, 2026.

Each quarter, investors track ALBBY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALBBY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

ALBBY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

ALBBY earnings · 4 questions

Alibaba Health Information Technology Limited's next earnings report is expected around September 1, 2026. ALBBY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALBBY historically reports after market close (AMC).

ALBBY earnings datewhen is ALBBY earningsALBBY next earnings datewhen does ALBBY report earningsALBBY earnings calendar

▸ Source: FMP · Alibaba Health Information Technology Limited SEC filings · US GAAP · Alibaba Health Information Technology Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026